Elevated baseline CTC counts are linked to worse overall survival, progression-free survival, and treatment response in cancer patients. In prostate cancer, patients with five or more CTCs at ...

Circulating tumor cells were first described in 1869 by Thomas Ashworth, an Australian pathologist who observed them in a peripheral blood sample taken from a patient with metastatic cancer. 1 They ...

Elevated baseline CTC count in hormone-sensitive prostate cancer is linked to worse overall survival and treatment response. Liquid biopsy can measure CTC count, providing a non-invasive method to ...

Circulating tumor cells (CTCs), originating from primary neoplastic tissues, infiltrate blood vessels, migrate through the bloodstream, and establish secondary tumor foci. The detection of CTCs holds ...

Renal cell carcinoma is the most common form of kidney cancer. It can take time to fully process a diagnosis and what, exactly, it may mean. Developing a good understanding of your disease—and ...

Enhanced Detection of Druggable Mutations in Non–Small Cell Lung Cancer Using Targeted Collection of Bronchial Washing Fluid Compared With Plasma and Tumor Tissue Ninety-nine patients with resectable ...